Interactions between a plasma-activated medium and cancer cells

被引：0

作者：

Tanaka H. ^{[1
]}

Mizuno M. ^{[1
]}

Kikkawa F. ^{[1
]}

Hori M. ^{[1
]}

机构：

[1] Nagoya University, Nagoya

来源：

Tanaka, Hiromasa (htanaka@plasma.engg.nagoya-u.ac.jp) | 1600年 / Begell House Inc.卷 / 06期

关键词：

Cancer cells;

D O I：

10.1615/PlasmaMed.2016015838

中图分类号：

学科分类号：

摘要：

A plasma-activated medium (PAM) is a medium that is irradiated with plasma; PAMs have garnered much attention from the plasma medicine community. PAMs induce apoptosis in many types of cancer cells and have a clinical benefit, especially in disseminated cancers such as peritoneal disseminated ovarian cancer and gastric cancer. Although the effectiveness of PAMs has been extensively reported, the mechanisms of the selective killing of cancer cells by PAMs still remain to be elucidated. Systems biology is a key to understanding the origins of the differences in cellular sensitivities to PAM. © 2016 by Begell House, Inc.

引用

页码：101 / 106

页数：5

共 50 条

[21] Hydrogen peroxide in plasma-activated liquid and radiation-conditioned medium for cancer treatment
Harley, Juliette C.
Cummins, Caitlin
Suchowerska, Natalka
Lo, Helen
Choong, Ee Siang
McKenzie, David R.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 61 - 61
[22] Novel Intraperitoneal Treatment With Non-Thermal Plasma-Activated Medium Inhibits Metastatic Potential of Ovarian Cancer Cells
Kae Nakamura
Yang Peng
Fumi Utsumi
Hiromasa Tanaka
Masaaki Mizuno
Shinya Toyokuni
Masaru Hori
Fumitaka Kikkawa
Hiroaki Kajiyama
Scientific Reports, 7
[23] Plasma-activated medium triggers cell death and the presentation of immune activating danger signals in melanoma and pancreatic cancer cells
Amalia Azzariti
Rosa Maria Iacobazzi
Roberta Di Fonte
Letizia Porcelli
Roberto Gristina
Pietro Favia
Francesco Fracassi
Ilaria Trizio
Nicola Silvestris
Gabriella Guida
Stefania Tommasi
Eloisa Sardella
Scientific Reports, 9
[24] Synergistic effect of plasma-activated medium and novel indirubin derivatives on human skin cancer cells by activation of the AhR pathway
Rebl, Henrike
Sawade, Marie
Hein, Martin
Bergemann, Claudia
Wende, Manuela
Lalk, Michael
Langer, Peter
Emmert, Steffen
Nebe, Barbara
SCIENTIFIC REPORTS, 2022, 12 (01)
[25] Novel Intraperitoneal Treatment With Non-Thermal Plasma-Activated Medium Inhibits Metastatic Potential of Ovarian Cancer Cells
Nakamura, Kae
Peng, Yang
Utsumi, Fumi
Tanaka, Hiromasa
Mizuno, Masaaki
Toyokuni, Shinya
Hori, Masaru
Kikkawa, Fumitaka
Kajiyama, Hiroaki
SCIENTIFIC REPORTS, 2017, 7
[26] Advances of Plasma-Activated Solutions for Cancer Therapy
Zhang, Hao
Zhang, Jishen
Xu, Dehui
Liu, Dingxin
Rong, Mingzhe
Diangong Jishu Xuebao/Transactions of China Electrotechnical Society, 2023, 38 : 231 - 246
[27] Plasma-activated medium induces apoptosis in chemotherapy-resistant ovarian cancer cells: High selectivity and synergy with carboplatin
Rasouli, Milad
Mehdian, Hassan
Hajisharifi, Kamal
Amini, Elaheh
Ostrikov, Kostya
Robert, Eric
PLASMA PROCESSES AND POLYMERS, 2021, 18 (09)
[28] Plasma-activated medium triggers cell death and the presentation of immune activating danger signals in melanoma and pancreatic cancer cells
Azzariti, Amalie
Iacobazzi, Rosa Maria
Di Fonte, Roberta
Porcelli, Letizia
Gristina, Roberto
Favia, Pietro
Fracassi, Francesco
Trizio, Ilaria
Silvestris, Nicola
Guida, Gabriella
Tommasi, Stefanie
Sardella, Eloisa
SCIENTIFIC REPORTS, 2019, 9 (1)
[29] Effect of plasma-activated medium on the decrease of tumorigenic population in lymphoma
Wada, Naoki
Ikeda, Jun-Ichiro
Tanaka, Hiromasa
Sakakita, Hajime
Hori, Masaru
Ikehara, Yuzuru
Morii, Eiichi
PATHOLOGY RESEARCH AND PRACTICE, 2017, 213 (07) : 773 - 777
[30] Histone deacetylase inhibitors stimulate the susceptibility of A549 cells to a plasma-activated medium treatment
Adachi, Tetsuo
Kano, Ayame
Nonomura, Saho
Kamiya, Tetsuro
Hara, Hirokazu
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2016, 606 : 120 - 127

← 1 2 3 4 5 →